Hyperthermia in gynecologic cancers

The opinion from most of the current data is that malignant tumors may be more heat sensitive than normal tissues. Hyperthermia has been tested in both randomized and non-randomized trials in gynecologic cancers, but has not found a place currently, as there is scarce data. As a consequence, adding this tool into the conventional methods of cervical cancer and ovarian cancer treatment has not been supported. Hyperthermia modifies the effects of not only ionizing radiation but also a number of chemotherapeutic agents. The use of hyperthermia in cervical cancer is of interest to the radiotherapist, not only because it sensitizes cells to the lethal effects of X-rays but even more because hypoxic cells which are most resistant to X-rays appear to be most sensitive to hyperthermia. Most of the data on the efficacy of intraperitoneal infusion with hyperthermia comes from experimental studies or some phase I/II investigations. Since intraperitoneal chemotherapy is potentiated by hyperthermia in areas which are at high risk for recurrence, further study maybe indicated. The current role for hyperthermia in ovarian cancer remains experimental. Additional trials to test the value of hyperthermia in patients treated with concurrent chemotherapy and radiation are imperative, and good news is expected from the ongoing studies.

Hyperthermia; Thermal effect; Gynecologic cancer; Therapy

[1] Busch W.: "Uber den eintluss welchen heftigere erysipeln zuweilen auf organisierte neubildungen ausuben". Verhandl. Naturh Preuss, Rhein. Westphal., 1866, 23, 28.

[2] Westermark H.: "Uber die behandlung des ulcerirended cerv1xcarcinoms. Mittel Konstanter Warme". Zbl. Gynak., 1898, 1335.

[3] Percy J.F: "Heat in the treatment of carcinomas of the uterus". Surg. Gynec. Obstet., 1916, 22, 77.

[4] Warren S.L.: "Preliminary study of the effect of artificial upon hopeless tumor cases". Sam. J. Roentgenol., 1935, 33, 57.

[5] Woodhall B., Pickrill K.L., Georgiade N.G., Mahalev M.S., Dukes H.T: "Effect of hyperthermia upon cancer chemotherapy - Application to external cancer of head and face structures". Ann. Surg.,1960, 151, 750.

[6] Loeb L.: "Uber Transplantation von Tumoren". Virchow's Arch. Path. Anat., 1903, 172, 345.

[7] Jensen C.O.: "Experimentelle U ntersuchungen Krelas bei Mausen". Zentralblat Bakteriol., 1903, 34, 28.

[8] Ehrlich P.: "Experimentelle Studien an Mause tumoren". Z. Krebsforsch., 1907, 5, 59.

[9] Haaland M.: "Contributions to the study of the development of sarcomas under experimental conditions". Imp. Cancer Res. Fund. Rep., 1908, 175.

[10] Vidal E.: "Travaux de la Deuxieme Conference Internationale pour l'Etude du Cancer". Paris, 1911, 160.

[11] Westermark H.: "The effect of heat upon rat tumors". Skand. Arch. Physiol., 1927, 52, 257.

[12] Hahn G.M.: "Hyperthermia and Cancer". New York and London: Plenum Press, 1982.

[13] Pleham H.R.B.: "Speculations on the function of the major heat shock proteins". Cell., 1986, 46, 959.

[14] Dewey W.C., Freeman M.L., Raaphorst G.P. et al.: "Cell biology of hyperthermia and radiation". In: Radiation Biology in Cancer Research, Meyn R.E. & Withers H.R. (eds.), New York: Raven Press, 1980, 589.

[15] Song C.W., Kang M.S., Rhee J.G., Levitt S.H.: "Effect of hyperthermia on vascular function. pH and cell survival". Radiology, 1980, 137, 795.

[16] Fajardo L.F., Egbert B., Marmor J., Hahn G.M.: "Effects of hyperthermia in a malignant tumor". Cancer, 1980, 45, 613.

[17] Marmor J.B., Hilerio J.G., Hahn G.M.: "Tumor eradication and cell survival after localized hyperthermia induced by ultrasound". Cancer Res., 1979, 39, 2166.

[18] Crile G.: "Selective destruction of cancers after exposure to heat". Ann. Surg., 1962, 156, 404.

[19] Chen TT, Heidelberger C.: "Quantitative studies on malignant transformation of mouse prostate cells by carcinogenic hydrocarbons in vitro". Int. J. Cancer, 1969, 4, 166.

[20] Levine E.M., Robbins E.B.: "Differential temperature sensitivity of normal and cancer cells in culture". J. Cell. Comp. Physiol., 1980, 76, 373.

[21] Goldin E.M., Leeper D.B.: "The effect of reduced pH on the induction of thermotolerance". Radiology, 1981, 141, 505.

[22] Overgaard J., Nielsen O.S.: "The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia". Ann. NY Acad. Sci., 1980, 335, 254.

[23] Loggie B.W., Fleming R.A., Geisinger K.R.: "Cytolog1c assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis". Acta Cytol., 1996, 40, 1154.

[24] Kober F., Heiss A., Roka R.: "Diffuse and gross peritoneal carcinomatosis treated by intraperitoneal hyperthermic chemoperfusion". Cancer Treat. Res., 1996, 82, 211.

[25] Hahn G.M., Braun J., Har-Kedar I.: "Thermochemotherapy: synergism between hyperthermia(42-43C) and Adriamycin(or bleomycin) in mammalian cell inactivation". Proc. Natl. Acad. Sci USA, 1975, 72, 937.

[26] Overgaard J.: "Combined Adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo". Cancer Res., 1976, 36, 3077.

[27] Kim J.H.: "Combined hyperthermia and radiation therapy in cancer treatment: current status". Cancer Invest., 1984, 2, 69.

[281 Prionas S.D., Kapp D.S., Goffinet D.R. et al.: "Thermometry of interstial hyperthermia given as an adjuvant to brachytherapy for treatment of carcinoma of the prostate". Int. J. Radial. Oneal. Biol. Phys., 1994, 1 (28), 151.

[29] Gibbs F.A.:'Thermal mapping in experimental cancer treatment with hyperthermia: description and use of a semi-automated system". Int. J. Radiat. Oncol. Biol. Phys., 1983, 9, 1057.

[30] Overgaard J.: "Rationale and problems in the design of clinical studies". In: "Hyperthermia Oncology" , Overgaard J. (ed.) London: Taylor & Francis LTD, 1984, 2, 325.

[31] Scott R.S., Johnson R.J.R., Kowal H. et al.: "Hypertherm1a rn combination with radiotherapy: A review of five years experience in the treatment of superficial tumors". Int. J. Radiat. Oneal. Biol. Phys., 1983, 9, 1327.

[32] Hornback N.B., Shupe R.E., Shidnia H. et al.: "Advanced Stage IIIB cancer of the cervix treatment by hyperthermia and radiation". Gynecol. Oneal., 1986, 23, 160.

[33] Sharma S., Sandhu A.P., Patel F.D., Ghoshal S., Gupta B.D., Yadav N.S.: "Side-effects of local hyperthermia: results of a prospectively randomized clinical study". Int. J. Hyperthermia， 1990, 6, 279.

[34] Dinges S.. Harder C., Wurm R., Buchali A., Blohmer J., Gellermann J. et al.: "Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial". Strahlenther. Onkol., 1998, 174, 517.

[35] Arcangeli G., Ciridall A., Creton G. et al.: "Tumor control and therapeutic gain with different schedules of combined radiotherapy and local external hyperthermia in human cancer". Int. J. Radial. Oneal. Biol. Phys., 1983, 9, 1125.

[36] Kapp D.A., Bagshaw M.A., Meyer J.L. et al.: "Hyperthermia as an adjuvant to radiation in the treatment of superficial metastases· A randomized trial of two vs six heat treatments". Abstract Bf 4. 34'" Annual meeting of the Radiation Research Society, Las Vegas 1986 April 12-17.

[37] Perez C.A., Gillespie B., Pajak T., Hornback N.B., Emami B., Rubin P.: "Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome. A report by RTOG". Int J. Radiat. Oneal. Biol. Phys., 1989, 16, 551.

[38] Van der Zee J., Gonzalez Gonzalez D., Van Rhoon G.C., Van Dijk J.D., Van Putten W.L., Hart A.A.: "Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours : a prospective, randomized, multicentre trial Dutch Deep Hyperthermia Group". Lancet, 2000, 355, 1119.

[39J Hornback N.B., Shidnia H., Shupe R.E. et al.: "Advanced stage IIIB cancer of the cervix treatment by hyperthermia and irradiation". Gynecol. Oneal., 1986, 3, 160.

[40] Bloss J.D., Berman M.L., Syed N. et al.: "Treatment of advanced carcinoma of the uterine cervix with interstitial radiotherapy and hyperthermia". Endocurietherapy/Hyperthermia Oneal., 1992, 8, 145.

[41] Perez C.A., Pajak T., Emami B., Hornback N.B.. Tupchong L., Rubin P.: "Randomized Phase JIJ study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: Final report by the Radiation Therapy Oncology Group (RTOG)". Am. J. Clin. Oneal. (CCT), 1991, 14, 133.

[42] Emami B., Myerson R.J., Cardenes H. et al.: "Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (I/wk vs 2/wks)". Int. J. Radiat. Oneal. Biol. Phys., 1992, 29, 169.

[43] Sharma S., Patel F.D., Sandhu A.P.S. et al.: "A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix. With radiotherapy". Endocurietherapy/Hyperthermia Oncol., 1989, 5, 151.

[44] Vora N.L., Luk K.H., Forell B. et al.: "Interstitial local current field hypertharmia for advanced cancers of the cervix". Endocurietherapy/Hyperthermia Oncol., 1988, 4, 97.

[45] Emami B., Scott C., Perez C. et al.: "Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistant human tumors: a prospectively controlled randomized study by the RTOG". Int. J Radial. Oneal. Biol. Phys., 1993, 27 (suppl. 1), 155.

[46] Hahn G.M.: "Potential for therapy of drugs and hypertherrnia" Cancer Res., 1979, 39, 2264.

[47] Kowal C.D., Bertino J.R.: "Possible benefits of hypertherrnia to chemotherapy". Cancer Res., 1979, 39, 2285.

[48] Markman M.: "Intraperitoneal chemotherapy". Seminars in Oncology, 1991, 3, 248.

[49] Dvorak H.F., Senger D.R., Dvoark A.M.: "Fibrin formation: irnphcation for tumor growth and metastasis". In: "Hemostasis mechanisms and metastasis". Hohn K.V., Sloane B.F. (eds.). Boston: MA, Martinus Nijhoff, 1984.

[50] Gunji Y., Gorelik E.: "Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells". Cancer Res., 1988, 48, 5216

[51] Cohen D.J.. Robins H.l., Javid M.J.: "Sensitization of C6 ghoma to cmboplatin cytotoxicity by hyperthermia and thymidine". J Neurooncol., 1990, 9, 1.

[52] Giovanella B.C., Stehlin J.S. Jr., Morgan A.C.: "Selective lethal effect of supranormal temperatures on human neoplastic cells" Cancer Res., 1976, 36, 3944.

[53] Kimura E., Howell S.B.: "Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line". Cancer Chemother. Pharmacol., 1993, 32, 419.

[54] Gerad H., Egorin M.J., Whitacre M., Van Echo D.A., Aisner J.: "Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (II) and whole-body hyperthermia". Cancer Chemother. Pharmacol., 1983, 11, 162.

[55] Katschinski D.M., Wiedemann G.J., Mentzel M., Mulkerin D.L., Touhidi R., Robins H.l.: "Optimization of chemotherapy administrati on for clinical 41.8 degrees C whole body hyperhermia". Cancer Lett., 1997, 115, 195.

[56] Robins H.I., Cohen J.D., Schmitt C.L., Tutsch K.D.. Feierabend C., Arzoomanian R.Z. et al.: "Phase I clinical trial of carboplatin and 41.8 degree、C whole-body hyperthermia in cancer patients" J. Clin. Oneal., 1993, 11, 1787.

[57] Wiedemann G.J., Robins H.I., Gutsche S., Mentzel M., Deeken M., Katschinski D.M. et al.: "Ifosfamide. carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma". Eur. J. Cancer, 1996, 32A, 888.

[58] Markman M., George M., Hakes T. et al.: "Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer". J. Clin. Oneal., 1990, 8, 146.

[59] Van de Vaart P.J., Van der Vange N., Zoetmulder F.A. et al.: "Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin adduct formation in patients and ovarian cancer cell lines". Eur. J. Cancer, 1998, 34, 148.

[60] Los G., Sminia P., Wondergem J. et al.: "Optimization of intraperitoneal cisplatin therapy with regional hyperthermia in rats". Eur. J. Cancer, 1991, 27, 472.

[61] Formenti S.C., Shrivastava P.N., Saponzik M. et al.: "Abdominopelvic hyperthermia and intra-peritoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology". Int. J. Radiat. Oneal. Biol. Phys., 1996, 35, 993.

[62] Leopold K.A., Oleson J.R., Clarke-Pearson D. et al.: "lntraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma". Int. J. Radiat. Oneal. Biol. Phys., 1993, 27, 1245.

[63] Steller M.A., Egorin M.J., Trimble E.L. et al.: "A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatm as pnmary treatment of pauents wIth small-volume residual ovarian cancer". Cancer Chemother. Pharmacol., 1999, 43, 106.

[64] Nicoletto M.O., Padrini R., Galeotti F. et al.: "Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitixantrone in ovarian cancer". Cancer Chemother. Pharmacol., 2000, 45, 457.

[65] Rossi C.R., Foletto M.. Mocellin S. et al.: "Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study". Cancer, 2002, 94, 492.